Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1057)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (19)
  8. Conference Paper (15)
  9. Correspondence (12)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2698)
  2. Department of Medicine (2698)
  3. Hematologic Malignancies, Division of (2698)
  4. Population Sciences Research Program (744)
  5. Survivorship Research (655)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (782)
  2. Steven Horwitz (666)
  3. Maria Palomba (445)
  4. Ariela Noy (371)
  5. David Straus (360)
  6. Alison Moskowitz (358)

More People

Years
  1. 2025 (45)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (876)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (83)
  5. British Journal of Haematology (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (941)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2698)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: A multi-institution collaborative project
    Journal Article

    Kim, Y. H.; Tavallaee, M.; Sundram, U.; Salva, K. A.; Wood, G. S.; Li, S. F.; Rozati, S.; Nagpal, S.; Krathen, M.; Reddy, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Randomized phase II trial comparing obinutuzumab (GA101) with rituximab in patients with relapsed CD20(+) indolent B-cell non-Hodgkin lymphoma: Final analysis of the GAUSS study
    Journal Article

    Sehn, L. H.; Goy, A.; Offner, F. C.; Martinelli, G.; Caballero, M. D.; Gadeberg, O.; Baetz, T.; Zelenetz, A. D.; Gaidano, G.; Fayad, L. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Survivorship care planning after participation in communication skills training intervention for a consultation about lymphoma survivorship
    Journal Article

    Banerjee, S. C.; Matasar, M. J.; Bylund, C. L.; Horwitz, S.; Mc Larney, K.; Levin, T.; Jacobsen, P. B.; Parker, P.; Astrow, A.; Kissane, D. W.
    Translational Behavioral Medicine (2015)

    Fulltext@MSK | Save
  • Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model
    Journal Article

    Scarisbrick, J. J.; Prince, H. M.; Vermeer, M. H.; Quaglino, P.; Horwitz, S.; Porcu, P.; Stadler, R.; Wood, G. S.; Beylot-Barry, M.; Pham-Ledard, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • ACR Appropriateness Criteria® diffuse large B-cell lymphoma
    Journal Article

    Dabaja, B. S.; Advani, R.; Hodgson, D. C.; Dhakal, S.; Flowers, C. R.; Ha, C. S.; Hoppe, B. S.; Mendenhall, N. P.; Metzger, M. L.; Plastaras, J. P.; more...
    American Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
    Journal Article

    Hong, D.; Kurzrock, R.; Kim, Y.; Woessner, R.; Younes, A.; Nemunaitis, J.; Fowler, N.; Zhou, T.; Schmidt, J.; Jo, M.; more...
    Science Translational Medicine (2015)

    Fulltext@MSK | Save
  • Prognostic value of FDG PET/CT before allogeneic and autologous stem cell transplantation for aggressive lymphoma
    Journal Article

    Ulaner, G. A.; Goldman, D. A.; Sauter, C. S.; Migliacci, J.; Lilienstein, J.; Gönen, M.; Schöder, H.; Moskowitz, C. H.; Zelenetz, A. D.
    Radiology (2015)

    Fulltext@MSK | Save
  • Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: An analysis from the National LymphoCare Study
    Journal Article

    Casulo, C.; Day, B.; Dawson, K. L.; Zhou, X.; Flowers, C. R.; Farber, C. M.; Hainsworth, J. D.; Cerhan, J. R.; Link, B. K.; Zelenetz, A. D.; more...
    Annals of Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes of anticoagulant or antiplatelet use in patients with chronic lymphocytic leukemia or indolent non-Hodgkin's lymphoma in idelalisib trials
    Meeting Abstract

    Stilgenbauer, S.; Barrientos, J.; Ghia, P.; Pagel, J.; Salles, G.; Sharman, J.; Gurtovaya, O.; Kim, Y.; Philip, B.; Zelenetz, A. D.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Serum chemokines and cytokines in CLL patients treated with duvelisib, an oral dual inhibitor of PI3K-delta, gamma
    Meeting Abstract

    Douglas, M.; Allen, K.; Sweeney, J.; O'Brien, S.; Flinn, I.; Horwitz, S.; Byrd, J.; Patel, M.; Kahl, B.; Foss, F.; more...
    Haematologica (2015)

    Fulltext@MSK | Save